Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Hannah A. Hathaway

TitleLecturer
InstitutionUniversity of Colorado Denver - Denver Campus
DepartmentCLAS-Biology
Phone303/724-0373

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Dahl KD, Almeida AR, Hathaway HA, Bourne J, Brown TL, Finseth LT, Wood TL, Macklin WB. mTORC2 Loss in Oligodendrocyte Progenitor Cells Results in Regional Hypomyelination in the Central Nervous System. J Neurosci. 2023 01 25; 43(4):540-558. PMID: 36460463.
      View in: PubMed
    2. Kohnke S, Buller S, Nuzzaci D, Ridley K, Lam B, Pivonkova H, Bentsen MA, Alonge KM, Zhao C, Tadross J, Holmqvist S, Shimizu T, Hathaway H, Li H, Macklin W, Schwartz MW, Richardson WD, Yeo GSH, Franklin RJM, Karadottir RT, Rowitch DH, Blouet C. Nutritional regulation of oligodendrocyte differentiation regulates perineuronal net remodeling in the median eminence. Cell Rep. 2021 07 13; 36(2):109362. PMID: 34260928.
      View in: PubMed
    3. Gelb T, Pshenichkin S, Hathaway HA, Grajkowska E, Dalley CB, Wolfe BB, Wroblewski JT. Atypical signaling of metabotropic glutamate receptor 1 in human melanoma cells. Biochem Pharmacol. 2015 Nov 01; 98(1):182-9. PMID: 26291396.
      View in: PubMed
    4. Hathaway HA, Pshenichkin S, Grajkowska E, Gelb T, Emery AC, Wolfe BB, Wroblewski JT. Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism. Neuropharmacology. 2015 Jun; 93:199-208. PMID: 25700650.
      View in: PubMed
    5. Gelb T, Hathaway HA, Wroblewski JT. Triple threat treatment: Exploiting the dependence receptor properties of metabotropic glutamate receptor 1 against melanoma. Mol Cell Oncol. 2014 Oct-Dec; 1(4):e969163. PMID: 27308372.
      View in: PubMed
    6. DiRaddo JO, Miller EJ, Hathaway HA, Grajkowska E, Wroblewska B, Wolfe BB, Liotta DC, Wroblewski JT. A real-time method for measuring cAMP production modulated by Gai/o-coupled metabotropic glutamate receptors. J Pharmacol Exp Ther. 2014 Jun; 349(3):373-82. PMID: 24659805.
      View in: PubMed
    7. B?raud D, Hathaway HA, Trecki J, Chasovskikh S, Johnson DA, Johnson JA, Federoff HJ, Shimoji M, Mhyre TR, Maguire-Zeiss KA. Microglial activation and antioxidant responses induced by the Parkinson's disease protein a-synuclein. J Neuroimmune Pharmacol. 2013 Mar; 8(1):94-117. PMID: 23054368.
      View in: PubMed
    8. Emery AC, DiRaddo JO, Miller E, Hathaway HA, Pshenichkin S, Takoudjou GR, Grajkowska E, Yasuda RP, Wolfe BB, Wroblewski JT. Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish ?-arrestin-mediated from G protein-mediated signaling. Mol Pharmacol. 2012 Aug; 82(2):291-301. PMID: 22584219.
      View in: PubMed
    9. Goldenberg NA, Jacobson L, Hathaway H, Tripputi M, Primeaux J, Child J. Anti-Xa stability of diluted dalteparin for pediatric use. Ann Pharmacother. 2008 Apr; 42(4):511-5. PMID: 18349310.
      View in: PubMed
    Hathaway's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (101) concept(s)
    _
    Co-Authors Expand Description
    See all (2) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)